Tango Therapeutics

Tango Therapeutics

Tango Therapeutics

Type
B2c
Founded
2017
Raised
$55M
Follow us
Alexa global traffic share
Latest funding
$55,000,000
Venture capital (Series A) - 2017
Third Rock Ventures
Team Size
10+
Employees
MedCity News

Gilead Sciences, Tango Therapeutics join forces on immuno-oncology

$55,000,000 Venture capital (Series A)
businesswire

Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment